Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A13493" target="_blank" >RIV/00216208:11110/12:13493 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/12:13493
Result on the web
<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420792/pdf/CRIM.HEMATOLOGY2012-369086.pdf" target="_blank" >http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420792/pdf/CRIM.HEMATOLOGY2012-369086.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
Original language description
Epigenetic therapy with hypomethylating agent (5-azacytidine; AZA) is common in the management of specific subtypes of myelodysplastic syndrome (MDS), but there are only few studies in chronic myelomonocytic leukemia (CMML) patients. In this paper our experience with 3 CMML patients treated with AZA is described.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Case Reports in Hematology
ISSN
2090-6560
e-ISSN
—
Volume of the periodical
2012
Issue of the periodical within the volume
Article ID 369086
Country of publishing house
US - UNITED STATES
Number of pages
4
Pages from-to
1-4
UT code for WoS article
—
EID of the result in the Scopus database
—